And MK 1293 is for? I don't see it in our pipeline?When is the PDUFA date for MK-1293?
And MK 1293 is for? I don't see it in our pipeline?
MK-1293 is an investigational insulin glargine candidate being evaluated for the treatment of patients with type 1 and type 2 diabetes. For further information on clinical trials please refer to: http://clinicaltrials.gov/ct2/results?term=mk-1293
You need not worry about a pipeline, at least Merck's pipeline, because you won't be around to sell anything!And MK 1293 is for? I don't see it in our pipeline?
When is the PDUFA date for MK-1293?